Meeting Report
2022–2023 Drug Updates: Investigational Therapeutics in the Pipeline
Presented by Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP
From UI Health, Chicago, Illinois
Presenter’s disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2024;15(3):182–185 |
https://doi.org/10.6004/jadpro.2024.15.3.5 |
© 2024 BroadcastMed LLC
ABSTRACT
During JADPRO Live 2023, Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP, discussed investigational therapeutic agents in the drug development pipeline. Dr. Cuellar highlighted new drug classes, novel mechanisms of action, and safety profiles that advanced practitioners should be aware of.
For access to the full length article, please
sign in.
